Objectives. NLR (neutrophil-lymphocyte ratio) and PLR (platelet-lymphocyte ratio) are prognostic markers of diff erentiated thyroid cancers. In our study, we evaluated NLR, PLR and C-reactive protein (CRP) for predicting the occurence of diff erentiated thyroid cancer. Th is is the fi rst study that compares NLR and PLR to C-reactive protein indiff erantiated thyroid cancer not only papillary cancer but also folliculer cancer.
Papillary and follicular cancers are considered to be diff erentiated cancers and patients with these tumors are oft en treated similarly despite the numerous biologic diff erences. Most anaplastic (undiff erentiated) cancers appear to arise from the diff erentiated ones (Tuttle 2017) . Papillary thyroid carcinoma is the most common type of the diff erentiated thyroid carcinoma (Lang et al. 2014) . Despite its relatively good prognosis with a 10-year, cancer specifi c survival >90%, local, and regional recurrence is common (Lang et al. 2007) .
Th ere is an increasing and consistent evidence that the infl ammation is related to the cancer development and progression (Coussens and Werb 2002; Whiteside 2008; Nozawa et al. 2006) . Systemic infl ammatory markers, including C-reactive protein, albumin concentration, and neutrophil to lymphocyte ratio (NLR) have recently been shown to be independent prognostic factors in the cancer patients (McMillan 2013; Guthrie et al. 2013) . Th e NLR has been shown to be a convenient and inexpensive prognostic biomarker in many human cancers (Azab et al. 2012; Kishi et al. 2009; Wang et al. 2011 ). Platelet to lymphocyte ratio (PLR) is a novel marker. Platelet counts as an infl ammation marker and is involved in the progress of tumor invasion (Kim et al. 2014) . Th ese markers can be easily, inexpensively, and reproducibly assayed, enhancing the ability to evaluate the prognosis in the cancer patients.
Many studies have reported that infl ammation is associated with the cancer prognosis. Unlike other types, few studies have reported about the thyroid cancer. Seretis et al. (2013) have compared the NLR between with an incidental papillary microcarcinoma and those with a benign goiter only and found that NLR was signifi cantly higher in carcinoma patients. Liu et al. (2013) have studied the correlation between the preoperative NLR and the tumor characteristics. Th ey have found that NLR is signifi cantly higher with large sized tumors. Kim et al. (2014) have reported the associations of NLR with disease-free and overall survival. Th ey have found out that higher NLR was a negative prognostic marker for disease-free survival.
In the view of these fi ndings, NLR and PLR are prognostic markers of diff erentiated thyroid cancers. In our study, we evaluated NLR, PLR, and C-reactive protein for predicting the occurrence of diff erentiated thyroid cancer. Th is is the fi rst study that compares NLR and PLR to C-reactive protein in diff erentiated thyroid cancer not only the papillary cancer but also the follicular one.
Subjects and Methods
Subjects. Th is study includes 51 papillary carcinoma, 42 papillary microcarcinoma, and 31 follicular carcinoma patients attending our outpatient Endocrinology Clinic at Erzurum Region Training and Research Hospital between 2009 and 2014. Th e control group includes 50-age, sex and body mass index matched healthy subjects. Th e control group was chosen between post operative benign nodular goiter patients. All the diff erential thyroid carcinoma patients were diagnosed histopathologically. Blood counts and CRP were measured at the day before surgery. Th yroglobulin was measured 6 months aft er an operation. Ethics Committee of Erzurum Region Training and Research Hospital approved the study design. All the study subjects provided written informed consent.
Laboratory assessment. Individual types of the diff erentiated cancers were evaluated histopathologically from the post-operative samples by pathology department of Erzurum Region Training and Research Hospital.
Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ration (PLR) were calculated from full blood count. Th e Beckman Coulter LH 750 (impedance method) analyzer was used for complete blood counts.
Th yroglobulin and C-reactive protein (CRP) levels were measured by standard laboratory methods on a biochemistry autoanalyzer (Beckman Coulter AU 2700 Plus clinical chemistry autoanalyzer) with the company's original kits (CRP N: 0-1 mg/dl).
Statistical analysis. Data are presented as mean ± SD. Th e IBM SPSS Statistics version 17 was used for statistical analysis. Student's t-test was done to fi nd the signifi cance of diff erence between means whenever applicable. One tailed Pearson's correlation test was done to fi nd the correlation between various variables. Linear regression analysis was done whenever appropriate. Chi square test, Chi square with Yates correction and Fisher's exact test, wherever applicable, were used to test the association between two fi ndings. Th e receiver operating characteristic (ROC) curve analysis assessed the cut-off of NLR and PLR with the best diagnostic accuracy for detecting differentiated thyroid cancers.
Results
NLR, PLR and CRP levels and demographic features of the all groups are shown in Table 1 . As each group was compared with other control group levels were signifi cantly lower than other cancer groups (p>0.05).
Th yroglobulin levels were measured at the 6 th month. Th e results are as following: 11.32±51.50 ng/ml in papillary cancer, 0.84±2.93 ng/ml in papillary microcancer, 58.78±106.68 ng/ml in follicular cancer, and 1.15±2.65 ng/ml in control group. As thyroglobulin levels of each group compared with other follicular cancer group result was signifi cantly higher than control, papillary and papillary microcancer group (p=0.002, p=0.009 and p=0.000; respectively). To assess the correlation between NLR and PLR, a Pearson correlation analysis was performed on each variable (Table 2) . Th ere were positive correlations between tumor diameter, age, white blood cell (WBC) and thyroglobulin levels. Th ere were also positive correlations between NLR, PLR and CRP levels.
Th e multiple regression analysis of NLR and other risk factors was performed (Table 3) . Age, gender, BMI and CRP were independent predictive factors of NLR. Adjustment for other these factors did not alter these relative risks. NLR and PLR were more successful in diagnosing thyroid cancer than CRP, which has ACU value 0.58 (p=0.28). AUC value of NLR was 0.831 (p=0.000) and PLR was 0.796 (p=0.000). Th e results of ROC analysis are shown in Figure 1 .
Discussion
NLR is an independent prognostic factor of survival in patients with upper gastrointestinal cancers and several types of solid organ malignancies (Walsh et al. 2005; Jung et al. 2011; Chen et al. 2015; Duzlu et al. 2015; Langsenlehner et al. 2015; Okamura et al. 2015; Song et al. 2015; Szkandera et al. 2015; Ji et al. 2016) . However, there are a few studies regarding the thyroid cancers. Seretis et al. (2013) have observed that NLR was signifi cantly elevated in patients with incidental papillary microcarcinoma and thyroid cancers.
In the study of Kim et al. (2014) , prognostic importance of NLR with advanced papillary thyroid cancer have been described. Th ey used diff erent cutoff for NLR and found that despite heterogeneous cutoff s higher NLR was associated with more advanced stage of the disease and more aggressive tumor behavior. Lang et al. (2007) have evaluated the preoperative NLR in papillary thyroid cancer. Th ey have found that although higher NLR may imply a poorer tumor profi le, it was not signifi cantly associated with a worse disease free survival and higher risk of occult central nodal metastasis in papillary thyroid cancer.
In our study, both control and study group of patients had thyroid nodules. Th yroid nodule is one of the common diseases originating from the endocrine system. Most such nodules are benign, but 5-10% have been reported to be malign. Diff erentiating the nodules is clinically important. A recent pilot study by Seretis et al. (2013) have shown that mean preoperative NLR was signifi cantly higher in patients with than without papillary thyroid microcarcinoma and thyroid cancer. In contrast, in the study of Liu et al. (2013) , NLR did not diff er in patients with thyroid cancer and those with follicular adenoma. In the study of Kim et al. (2014) , NLR was not an independent marker of thyroid malignancy but NLR was a marker for thyroid nodules, whether benign or malignant. Th ey also have suggested that NLR tended to be higher in patients with solid than cystic thyroid nodules (Kim et al. 2014) .
Th ese few studies regarding the thyroid cancer have shown that higher NLR is associated with the poor prognosis. However, in our study, we evaluated NLR, PLR, and CRP. Th is is the fi rst study to evaluate and compare all these parameters. In our study, we also compared diff erent types of thyroid cancers. All the previous studies published were about the papillary cancers, however, our study also includes follicular cancers.
In our study, we found out that higher NLR and PLR was associated with higher levels of thyroglobulin, which indicates worse survival. CRP levels were also associated with poorer tumor profi le but the determining rate was lower according to ROC analysis.
Th ere are few studies comparing NLR and CRP predictive values. Forget et al. (2015) have found that NLR was signifi cantly associated with postoperative complications of major abdominal surgery than CRP.
In the study of Turkmen et al. (2013) , has been indicated that PLR may better predict the infl ammation than NLR in the end stage of the renal disease. However, in our study, both NLR and PLR were better than CRP but NLR was also better than PLR. Th is diff erence could be because PLR count is an infl ammation marker and is involved in the progress of the tumor invasion.
As NLR and PLR are simple biomarkers, they can be easily determined as well as easily reproducible. Th ese facts make them great tools in the prognosis assessing probably more effi cient than CRP and they can be used in various types of population to determine the thyroid cancer survival and risk of recurrence.
In summary, we found that NLR and PLR are superior to CRP in the predicting of the occurrence of diff erential thyroid cancer. Further studies are needed to evaluate long term survival, risk of recurrence, and disease free stage. 
